Crowdonomics
All companies
Synovation Medical Group logo

Synovation Medical Group

Operating

Synovation Holdings LLC

Biotech · Pasadena, CA

Visit website

Operating in 40+ clinics across 4 states with $45.6M in 2024 revenue, Synovation Medical Group has spent 35 years developing its multidisciplinary pain care. We are pursuing exclusive new insurance contracts and implementing AI-driven efficiency to support our efforts in scaling nationwide.

Post-money valuation ⓘ
$109.8M
As of Apr 2026 · from Reg CF Offering (2025) · pre-money + amount raised, not a traded price
Total raised
$186,294
Across 1 round since 2025
Latest share price
$5.00
Reg CF Offering (2025) offering price

Financials

FY2023–FY2024 · from SEC filings · hover any figure for its source
$45.1M
−$2.6M
2023
$45.7M
−$1.3M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2023
FY2024
Income statement
Revenue
$45,133,928
$45,671,564
Cost of goods sold
$5,582,749
$10,354,807
Gross margin
88%
77%
Net income
-$2,623,253
-$1,304,133
Taxes paid
$0
$0
Balance sheet
Cash
$1,754,407
$475,813
Accounts receivable
$7,368,780
$9,466,227
Total assets
$55,336,577
$49,166,496
Short-term debt
$8,295,987
$7,898,141
Long-term debt
$47,960,970
$42,830,368
Total liabilities
$56,256,957
$50,728,509
Other
Headcount
—
64

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Post-money = pre-money + amount raised · caps marked
$109.8M
post-money
Reg CF Offering (2025)

A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.

Fundraising history

Reg CF Offering (2025)ClosedReg CF · Common Equity · via STARTENGINE PRIMARY LLC
Raised $186.3K / $5MInvestors 55Post-money $109.8M

Team

7 people
Clayton Varga, M.D.
CEO / Manager

With over 30 years of experience in pain management, Dr. Varga has led the development of multidisciplinary care models since 1989 and supports strategic growth initiatives.

Clayton Alexander Varga, M.D.
CEO / Manager
Damian Dyer
Chief Information Officer

With over 20 years of experience in information technology, Damian Dyer has served as CIO of Olios since 2010, driving technological innovation and growth within the company.

Matthew Talbot
Chief Operating Officer

Talbot oversees daily operations across Synovation Medical Group's practices and acts as the key liaison with IPAs, ensuring provider satisfaction and efficient organizational coordination.

Natalie Paluck
Chief Financial Officer

Former Controller at Care Logistics/Jackson Healthcare, she brings deep experience in financial strategy, KPIs, and supporting scalable growth across healthcare organizations.

Natalie L Paluck
CFO
Marc E. Lynch, DO
Medical Director

With more than 28 years of professional healthcare services experience, Marc E. Lynch has led Synovation as Medical Director since 2012, while also contributing to healthcare leadership as President of Medical Staff at Kindred Healthcare.

Names and titles as disclosed on StartEngine, SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Delinquent

Filed 0 of 1 annual reports (FY2025)

Missing: 2025

55 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-UMay 4, 20260001611174-26-000004
    EDGAR
  • Form C/AFeb 27, 20260001611174-26-000002
    EDGAR
  • Form CDec 12, 20250001611174-25-000004
    EDGAR
Source: SEC EDGARCIK 0001611174DEShare price $5.00Last synced Aug 17, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.